Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Gross Profit (2018 - 2025)

Historic Gross Profit for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $10.1 million.

  • Exagen's Gross Profit rose 4432.03% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 1613.79%. This contributed to the annual value of $33.1 million for FY2024, which is 1241.17% up from last year.
  • As of Q3 2025, Exagen's Gross Profit stood at $10.1 million, which was up 4432.03% from $10.4 million recorded in Q2 2025.
  • Exagen's 5-year Gross Profit high stood at $10.4 million for Q2 2025, and its period low was $1.5 million during Q2 2022.
  • Moreover, its 5-year median value for Gross Profit was $7.8 million (2021), whereas its average is $7.4 million.
  • Per our database at Business Quant, Exagen's Gross Profit tumbled by 7912.85% in 2022 and then soared by 44325.92% in 2023.
  • Quarter analysis of 5 years shows Exagen's Gross Profit stood at $7.8 million in 2021, then decreased by 15.77% to $6.5 million in 2022, then grew by 24.77% to $8.1 million in 2023, then increased by 4.08% to $8.5 million in 2024, then rose by 18.85% to $10.1 million in 2025.
  • Its Gross Profit was $10.1 million in Q3 2025, compared to $10.4 million in Q2 2025 and $9.1 million in Q1 2025.